| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2010PLoSO...515195B |
| P356 | DOI | 10.1371/JOURNAL.PONE.0015195 |
| P932 | PMC publication ID | 3002961 |
| P698 | PubMed publication ID | 21179572 |
| P5875 | ResearchGate publication ID | 49703552 |
| P2093 | author name string | Chiara Braconi | |
| Nianyuan Huang | |||
| Takayuki Kogure | |||
| Tushar Patel | |||
| Erica Swenson | |||
| P2860 | cites work | Cancer risk in users of calcium channel blockers. | Q50956016 |
| Translational regulation by p38 mitogen-activated protein kinase signaling during human cholangiocarcinoma growth. | Q53378279 | ||
| Potentiation of kinesin spindle protein inhibitor-induced cell death by modulation of mitochondrial and death receptor apoptotic pathways. | Q53578688 | ||
| Marked elevation of serum interleukin-6 in patients with cholangiocarcinoma: validation of utility as a clinical marker | Q74397599 | ||
| Antihypertensive medication and their impact on cancer incidence: a mixed treatment comparison meta-analysis of randomized controlled trials | Q80837639 | ||
| Cholangiocarcinoma | Q82195092 | ||
| Worldwide trends in mortality from biliary tract malignancies | Q21093310 | ||
| Cancer statistics, 2007 | Q29547293 | ||
| Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors | Q29547463 | ||
| The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease | Q29547614 | ||
| Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production | Q29614596 | ||
| Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression | Q29615766 | ||
| Oral capecitabine for the treatment of hepatocellular carcinoma, cholangiocarcinoma, and gallbladder carcinoma | Q33361810 | ||
| Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States | Q33949931 | ||
| Changing international trends in mortality rates for liver, biliary and pancreatic tumours | Q33962674 | ||
| Phase II study of erlotinib in patients with advanced biliary cancer | Q33997258 | ||
| Epigenetic regulation of microRNA-370 by interleukin-6 in malignant human cholangiocytes | Q34648030 | ||
| IL-6 activates serum and glucocorticoid kinase via p38alpha mitogen-activated protein kinase pathway | Q34804514 | ||
| Over-expression of interleukin-6 enhances cell survival and transformed cell growth in human malignant cholangiocytes | Q34881846 | ||
| Interleukin-6 decreases senescence and increases telomerase activity in malignant human cholangiocytes | Q34882042 | ||
| Inverse association between prostate cancer and the use of calcium channel blockers | Q35671014 | ||
| Advances in the diagnosis, evaluation and management of cholangiocarcinoma | Q36426732 | ||
| Treatment of children with acute promyelocytic leukemia: results of the first North American Intergroup trial INT0129 | Q36430103 | ||
| Calcium and cancer: targeting Ca2+ transport | Q36856463 | ||
| Cholangiocarcinoma and its management | Q36999338 | ||
| The wolf in sheep's clothing: the role of interleukin-6 in immunity, inflammation and cancer | Q37080407 | ||
| L-type calcium channel blockers reverse docetaxel and vincristine-induced multidrug resistance independent of ABCB1 expression in human lung cancer cell lines | Q38348538 | ||
| Diagnostic utility of interleukin-6 (IL-6) for primary bile duct cancer and changes in serum IL-6 levels following photodynamic therapy | Q38505216 | ||
| Candidate therapeutic agents for hepatocellular cancer can be identified from phenotype-associated gene expression signatures. | Q39840008 | ||
| Histone deacetylase inhibitor MS-275 alone or combined with bortezomib or sorafenib exhibits strong antiproliferative action in human cholangiocarcinoma cells | Q40088575 | ||
| Interleukin-6 contributes to growth in cholangiocarcinoma cells by aberrant promoter methylation and gene expression | Q40213105 | ||
| Sorafenib alone or as combination therapy for growth control of cholangiocarcinoma | Q40246733 | ||
| Involvement of p38 mitogen-activated protein kinase signaling in transformed growth of a cholangiocarcinoma cell line | Q40836231 | ||
| Relationship between interleukin-6 and proliferation and differentiation in cholangiocarcinoma | Q41004779 | ||
| Induction of apoptosis by monastrol, an inhibitor of the mitotic kinesin Eg5, is independent of the spindle checkpoint | Q46080289 | ||
| Diagnostic role of serum interleukin 6 and CA 19-9 in patients with cholangiocarcinoma. | Q47975129 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | phenotype | Q104053 |
| cholangiocarcinoma | Q124292 | ||
| P304 | page(s) | e15195 | |
| P577 | publication date | 2010-12-16 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Targeting the IL-6 dependent phenotype can identify novel therapies for cholangiocarcinoma | |
| P478 | volume | 5 |
| Q35620650 | A combination of serum leucine-rich α-2-glycoprotein 1, CA19-9 and interleukin-6 differentiate biliary tract cancer from benign biliary strictures. |
| Q46243039 | Characterisation of the immune-related transcriptome in resected biliary tract cancers |
| Q28547244 | Chemical Library Screening and Structure-Function Relationship Studies Identify Bisacodyl as a Potent and Selective Cytotoxic Agent Towards Quiescent Human Glioblastoma Tumor Stem-Like Cells |
| Q50025185 | Clinical Significance of Soluble Intercellular Adhesion Molecule-1 and Interleukin-6 in Patients with Extrahepatic Cholangiocarcinoma |
| Q53090136 | Gankyrin promotes tumor growth and metastasis through activation of IL-6/STAT3 signaling in human cholangiocarcinoma. |
| Q38183539 | Hydrodynamic transfection for generation of novel mouse models for liver cancer research |
| Q37028411 | Liver carcinogenesis: rodent models of hepatocarcinoma and cholangiocarcinoma |
| Q47320115 | LncRNA LINC00880 promotes cell proliferation, migration and invasion while inhibiting apoptosis by targeting CACNG5 through the MAPK signaling pathway in spinal cord ependymoma. |
| Q47429093 | MIR21 drives resistance to Heat Shock Protein 90 inhibition in cholangiocarcinoma |
| Q37621790 | New insights into the molecular pathogenesis of intrahepatic cholangiocarcinoma |
| Q92730412 | Phosphatidylcholine Passes by Paracellular Transport to the Apical Side of the Polarized Biliary Tumor Cell Line Mz-ChA-1 |
| Q55021190 | Suppression of IL-6 Gene by shRNA Augments Gemcitabine Chemosensitization in Pancreatic Adenocarcinoma Cells. |
| Q38734433 | TG2 and NF-κB Signaling Coordinates the Survival of Mantle Cell Lymphoma Cells via IL6-Mediated Autophagy |
| Q55513254 | Translational Bioinformatics for Cholangiocarcinoma: Opportunities and Challenges. |
| Q34811043 | Tumour cell-derived extracellular vesicles interact with mesenchymal stem cells to modulate the microenvironment and enhance cholangiocarcinoma growth |
Search more.